SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

Share Price is delayed by 15 minutes
Get Live Data
48.65    0.95 (1.99%)
Bid:
47.80
Ask:
49.65
Spread: 1.85 (3.87%)
Market Cap: £193.68m
CLI Live PriceLast checked at - London Stock Exchange

Intraday CLS Holdings Share Chart

Director/PDMR Shareholding

30 Apr 2026 13:05

RNS Number : 6388C
CLS Holdings PLC
30 April 2026
 

CLS Holdings plc

 

(the "Company", the "Group")

 

Notification of Transaction of Persons Discharging Managerial Responsibilities ("PDMR")

 

CLS Holdings plc Long Term Incentive Plan ("LTIP")

 

 

CLS Holdings plc announces that Fredrik Widlund, Chief Executive Officer and Director of the Company, and Harry Stokes, Chief Financial Officer and Director of the Company, have been awarded nil cost options over a number of ordinary shares of 2.5 pence each in the Company ("Ordinary Shares") as set out below (the "Awards") on 29 April 2026.

 

PDMR Plan Participant

Award Plan

No of Ordinary Shares granted pursuant to Awards

Award Type

Fredrik Widlund

 

LTIP

 

950,407

Performance Share Award

475,203

Restricted Share Award

Harry Stokes

LTIP

443,877

Performance Share Award

221,938

Restricted Share Award

 

The terms of the Awards align to the new hybrid award policy envisaged under the new Directors' Remuneration Policy approved at the 2026 Annual General Meeting and as set out in the Annual Report and Accounts 2025.

 

Subject to the LTIP rules, the Awards will vest on the third anniversary of the date of grant, subject to continued service and the achievement of performance targets or underpin conditions (as relevant). Details of performance targets and underpin conditions can be found in the Directors' Remuneration Report within the Company's Annual Report and Accounts 2025.

 

Vested Awards will be subject to an additional two-year holding period (net of sales for tax).

 

The notification is made in accordance with the UK Market Abuse Regulation.

 

Enquiries:

David Fuller

Company Secretary

CLS Holdings plc

Tel: +44 (0) 20 7582 7766

 

Notification of Dealing Form

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name(s)

Fredrik Widlund

2

 

Reason for the notification

a)

Position/status

 

Chief Executive Officer

 

b)

Initial notification/amendment

 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

CLS Holdings plc

b)

LEI

 

213800A357TKB2TD9U78

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument

Ordinary Shares of 2.5p

 

Identification code: GB00BF044593

 

b)

Nature of the transaction

Award of nil cost options under the CLS Holdings plc Long Term Incentive Plan

c)

Price(s) and volume(s)

 Price

 

Volume

 

1. Nil

2. Nil

1. 950,407 (PSA)

2. 475,203 (RSA)

d)

- Aggregated information

- Price

 

N/A single transactions

Nil

e)

Date of the transaction

 

29 April 2026

f)

Place of the transaction

Outside a trading venue

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name(s)

Harry Stokes

2

 

Reason for the notification

a)

Position/status

 

Chief Financial Officer

 

b)

Initial notification/amendment

 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

CLS Holdings plc

b)

LEI

 

213800A357TKB2TD9U78

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument

Ordinary Shares of 2.5p

 

Identification code: GB00BF044593

 

b)

Nature of the transaction

Award of nil cost options under the CLS Holdings plc Long Term Incentive Plan

c)

Price(s) and volume(s)

 Price

 

Volume

 

1. Nil

2. Nil

1. 443,877 (PSA)

2. 221,938 (RSA)

d)

- Aggregated information

- Price

 

N/A single transactions

Nil

e)

Date of the transaction

 

29 April 2026

 

f)

Place of the transaction

Outside a trading venue

 

 

- end -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHAKKBKBBKDNQN
Date   Source Headline
11th Jun 20264:28 pmRNSDirector/PDMR Shareholding
2nd Jun 202610:23 amRNSDirector/PDMR Shareholding
29th May 202612:00 pmRNSTotal Voting Rights
28th May 20264:20 pmRNSDirector/PDMR Shareholding
26th May 20264:38 pmRNSTR-1: Notification of major holdings
22nd May 20265:04 pmRNSAdmission of Further Securities to Trading
15th May 20261:05 pmRNSApplication for Listing - Enhanced Scrip Dividend
13th May 202612:07 pmRNSDirector/PDMR Shareholding
30th Apr 20261:05 pmRNSDirector/PDMR Shareholding
29th Apr 20262:12 pmRNSDirector/PDMR Shareholding
27th Apr 20267:00 amRNSCLS announces sale of The Brix, Essen
23rd Apr 20264:00 pmRNSResult of AGM
16th Apr 20262:59 pmRNSScrip Dividend Reference Share Price
15th Apr 202612:32 pmRNSDirector/PDMR Shareholding
9th Apr 20263:07 pmRNSTR-1: Notification of major holdings
25th Mar 20269:58 amRNSTR-1: Notification of major holdings
23rd Mar 20264:05 pmRNSPublication of 2025 Annual Report & Notice of AGM
16th Mar 20265:46 pmRNSDirector/PDMR Shareholding
13th Mar 20263:45 pmRNSDirector/PDMR Shareholding
13th Mar 20267:00 amRNSAnnual Financial Results
13th Mar 20267:00 amRNSAnnual Financial Results
10th Feb 20264:03 pmRNSDirector/PDMR Shareholding
13th Jan 20264:37 pmRNSDirector/PDMR Shareholding
22nd Dec 20253:30 pmRNSChanges to the responsibilities of a director
22nd Dec 20253:30 pmRNSChanges to the responsibilities of a director
22nd Dec 20257:00 amRNSCitadel Place: Conditional sale & Planning update
22nd Dec 20257:00 amRNSCitadel Place: Conditional sale & Planning update
9th Dec 20253:12 pmRNSDirector/PDMR Shareholding
2nd Dec 20257:00 amRNSTrading Update
12th Nov 20254:12 pmRNSDirector/PDMR Shareholding
30th Oct 20257:00 amRNSBoard Change/CFO Appointment
16th Oct 20257:00 amRNSCLS leases 14,700 sqm at Gotic Haus, Dortmund
10th Oct 202511:00 amRNSDirector/PDMR Shareholding
15th Sep 20259:00 amRNSTR-1 Notification of Major Holdings
9th Sep 20253:48 pmRNSDirector/PDMR Shareholding
14th Aug 20255:13 pmRNSDirector/PDMR Shareholding
13th Aug 20257:01 amRNSHalf Yearly Results Announcement 2025
13th Aug 20257:00 amRNSBoard Appointment
11th Aug 20256:11 pmRNSDirector/PDMR Shareholding
7th Aug 20257:00 amRNSCLS secures over 8,000 sq. ft at The Coade
6th Aug 20257:00 amRNSCLS leases 2,165 sqm in Cologne
9th Jul 20259:49 amRNSDirector/PDMR Shareholding
3rd Jul 20251:51 pmRNSDirector/PDMR Shareholding
2nd Jul 20251:34 pmRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSCLS sells two properties in Germany
30th Jun 202511:48 amRNSBoard Change
11th Jun 20253:44 pmRNSDirector/PDMR Shareholding
3rd Jun 20252:57 pmRNSDirector/PDMR Shareholding
16th May 20254:35 pmRNSResult of AGM
13th May 20254:03 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.